Agger EM - Search Results

1

Different human vaccine adjuvants promote distinct antigen-independent immunological signatures tailored to different pathogens.

Knudsen NP, Olsen A, Buonsanti C, Follmann F, Zhang Y, Coler RN, Fox CB, Meinke A, D'Oro U, Casini D, Bonci A, Billeskov R, De Gregorio E, Rappuoli R, Harandi AM, Andersen P, Agger EM. Knudsen NP, et al. Among authors: agger em. Sci Rep. 2016 Jan 21;6:19570. doi: 10.1038/srep19570. Sci Rep. 2016. PMID: 26791076 Free PMC article.

2

Diagnosis of tuberculosis based on the two specific antigens ESAT-6 and CFP10.

van Pinxteren LA, Ravn P, Agger EM, Pollock J, Andersen P. van Pinxteren LA, et al. Among authors: agger em. Clin Diagn Lab Immunol. 2000 Mar;7(2):155-60. doi: 10.1128/CDLI.7.2.155-160.2000. Clin Diagn Lab Immunol. 2000. PMID: 10702486 Free PMC article.

3

Control of latent Mycobacterium tuberculosis infection is dependent on CD8 T cells.

van Pinxteren LA, Cassidy JP, Smedegaard BH, Agger EM, Andersen P. van Pinxteren LA, et al. Among authors: agger em. Eur J Immunol. 2000 Dec;30(12):3689-98. doi: 10.1002/1521-4141(200012)30:12<3689::AID-IMMU3689>3.0.CO;2-4. Eur J Immunol. 2000. PMID: 11169412 Free article.

4

Tuberculosis subunit vaccine development: on the role of interferon-gamma.

Agger EM, Andersen P. Agger EM, et al. Vaccine. 2001 Mar 21;19(17-19):2298-302. doi: 10.1016/s0264-410x(00)00519-3. Vaccine. 2001. PMID: 11257351

5

Antigen discovery and tuberculosis vaccine development in the post-genomic era.

Louise R, Skjøt V, Agger EM, Andersen P. Louise R, et al. Among authors: agger em. Scand J Infect Dis. 2001;33(9):643-7. doi: 10.1080/00365540110026971. Scand J Infect Dis. 2001. PMID: 11669220 Review.

6

Specific acquired resistance in mice immunized with killed mycobacteria.

Agger EM, Weldingh K, Olsen AW, Rosenkrands I, Andersen P. Agger EM, et al. Scand J Immunol. 2002 Nov;56(5):443-7. doi: 10.1046/j.1365-3083.2002.01152.x. Scand J Immunol. 2002. PMID: 12410793 Free article.

7

A novel TB vaccine; towards a strategy based on our understanding of BCG failure.

Agger EM, Andersen P. Agger EM, et al. Vaccine. 2002 Nov 22;21(1-2):7-14. doi: 10.1016/s0264-410x(02)00447-4. Vaccine. 2002. PMID: 12443657 Review.

8

PPE protein (Rv3873) from DNA segment RD1 of Mycobacterium tuberculosis: strong recognition of both specific T-cell epitopes and epitopes conserved within the PPE family.

Okkels LM, Brock I, Follmann F, Agger EM, Arend SM, Ottenhoff TH, Oftung F, Rosenkrands I, Andersen P. Okkels LM, et al. Among authors: agger em. Infect Immun. 2003 Nov;71(11):6116-23. doi: 10.1128/IAI.71.11.6116-6123.2003. Infect Immun. 2003. PMID: 14573626 Free PMC article.

9

Human T-cell responses to the RD1-encoded protein TB27.4 (Rv3878) from Mycobacterium tuberculosis.

Agger EM, Brock I, Okkels LM, Arend SM, Aagaard CS, Weldingh KN, Andersen P. Agger EM, et al. Immunology. 2003 Dec;110(4):507-12. doi: 10.1111/j.1365-2567.2003.01763.x. Immunology. 2003. PMID: 14632649 Free PMC article.

10

The influence of remaining live BCG organisms in vaccinated mice on the maintenance of immunity to tuberculosis.

Olsen AW, Brandt L, Agger EM, van Pinxteren LA, Andersen P. Olsen AW, et al. Among authors: agger em. Scand J Immunol. 2004 Sep;60(3):273-7. doi: 10.1111/j.0300-9475.2004.01471.x. Scand J Immunol. 2004. PMID: 15320884 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

100 results

Search Page

Filters